Adenocarcinoma in tubulovillous adenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Mesothelial Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.300 |
None |
1.000 |
2 |
|
2010 |
2011 |
Asbestos pleurisy
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of stomach stage III
|
disease |
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Metastatic Malignancy
|
disease |
|
Neoplastic Process
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant tumor of extrahepatic bile duct
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Pleural Diseases
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
15
|
|
0.310 |
None |
1.000 |
2 |
|
2013 |
2017 |
Hydrosalpinx (disease)
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Infections
|
Disease or Syndrome
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pleural Mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
19
|
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Uterine Cervicitis
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
22
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Epithelioid mesothelioma, malignant
|
disease |
Neoplasms
|
Neoplastic Process
|
32
|
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2019 |
Peritoneal adhesion
|
disease |
Digestive System Diseases; Skin and Connective Tissue Diseases
|
Acquired Abnormality
|
32
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Pancreatic adenocarcinoma metastatic
|
disease |
|
Neoplastic Process
|
32
|
2
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Carcinoma of extrahepatic bile duct
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
35
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Asbestosis
|
disease |
Respiratory Tract Diseases; Occupational Diseases
|
Disease or Syndrome
|
47
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
2015 |
2015 |
Salivary gland carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
47
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Intraductal papillary mucinous neoplasm
|
disease |
|
Neoplastic Process
|
50
|
2
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Secondary malignant neoplasm of peritoneum
|
disease |
|
Neoplastic Process
|
58
|
2
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Cholestatic liver disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
58
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Papillary serous endometrial carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
63
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Secondary malignant neoplasm of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
69
|
4
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Recurrent ovarian cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
71
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinoma, Pancreatic Ductal
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
82
|
|
0.310 |
None |
1.000 |
4 |
|
2003 |
2014 |
Thymic Carcinoma
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
82
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
MSI-high
|
disease |
|
Neoplastic Process
|
83
|
9
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |